UBS Group’s Modular Medical MODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$47.5K Buy
23,772
+19,076
+406% +$55.5K ﹤0.01% 7659
2026
Q2
$21.1K Buy
4,696
+4,073
+654% +$18.6K ﹤0.01% 8134
2026
Q1
$3.29K Sell
623
-72
-10% -$772 ﹤0.01% 9113
2025
Q4
$7.6K Buy
695
+688
+9,829% +$10.1K ﹤0.01% 8433
2025
Q3
$140 Sell
7
-46
-87% -$991 ﹤0.01% 9872
2025
Q2
$1.19K Buy
+53
New +$1.42K ﹤0.01% 9663
2025
Q1
– Sell
-164
Closed -$6.74K – 10542
2024
Q4
$6.74K Sell
164
-37
-18% -$2.14K ﹤0.01% 8535
2024
Q3
$13.6K Buy
201
+181
+905% +$9.8K ﹤0.01% 7581
2024
Q2
$937 Sell
20
-450
-96% -$22K ﹤0.01% 8727
2024
Q1
$26.1K Buy
470
+261
+125% +$14K ﹤0.01% 6801
2023
Q4
$11.4K Sell
209
-57
-21% -$2.19K ﹤0.01% 7393
2023
Q3
$9.27K Buy
266
+53
+25% +$1.69K ﹤0.01% 7145
2023
Q2
$6.27K Buy
+213
New +$8.64K ﹤0.01% 7380

Other funds holding MODD

UBS Group's MODD Position: Q3 2026 in Review

UBS Group increased its Modular Medical (MODD) stake by 406% in Q3 2026, buying an estimated $55.5K and bringing the position to 23,772 shares worth $47.5K. The position accounts for ﹤0.01% of the portfolio, ranked #7659.

UBS Group first reported a position in MODD in Q2 2023 and has held it in 13 quarters since. 10 funds tracked by Wall St. Rank hold MODD as of Q3 2026.

  • UBS Group held 23,772 shares of Modular Medical worth $47.5K as of Q3 2026.
  • UBS Group bought 19,076 Modular Medical shares in Q3 2026, an estimated $55.5K.
  • Modular Medical made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #7659 holding.
  • UBS Group first reported a position in Modular Medical in Q2 2023 and has held it in 13 quarters since.
  • 10 funds tracked by Wall St. Rank held Modular Medical as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.